Search results for "Growth hormone secretion"

showing 10 items of 13 documents

Study of pituitary secretion in relation to retinopathy in patients with juvenile diabetes mellitus.

1981

Fifteen juvenile diabetic patients with normal eye fundus, 6 with non proliferative retinopathy, 5 with proliferative retinopathy and 5 healthy control subjects were studied in order to investigate pituitary function in relation to diabetic retinopathy. ACTH values at 08(00) and 18(00), hPRL and TSh secretion in response to 200 microgram TRH i.v., and GH secretion in response to 500 mg oral L-dopa were evaluated. In all diabetic subjects, 08(00) ACTH levels were lower than in controls. Basal hPRL, TSH and GH values of the diabetics did not differ from those of the controls. No significant differences were found in hPRL levels in response to TRH, whereas significantly lower TSH responses wer…

AdultMaleendocrine systemPituitary glandmedicine.medical_specialtyAdolescentEndocrinology Diabetes and MetabolismThyrotropin-releasing hormoneThyrotropinAdrenocorticotropic hormoneLevodopaEndocrinologyAdrenocorticotropic HormoneInternal medicineDiabetes mellitusInternal MedicineMedicineHumansThyrotropin-Releasing HormoneDiabetic Retinopathybusiness.industryGeneral MedicineDiabetic retinopathymedicine.diseaseGrowth hormone secretionProlactinProlactinKineticsmedicine.anatomical_structureEndocrinologyDiabetes Mellitus Type 1Growth HormonePituitary GlandFemalebusinesshormones hormone substitutes and hormone antagonistsRetinopathyActa diabetologica latina
researchProduct

The neuroendocrinological profile of roxindole, a dopamine autoreceptor agonist, in schizophrenic patients

1995

Roxindole is a potent autoreceptor-selective dopamine agonist with additional properties as a serotonin reuptake inhibitor and 5-HT1A agonist. In order to get more insight into its mode of action in various psychiatric populations, we evaluated the effects of subchronic roxindole treatment on pituitary and adrenal hormone secretion, i.e. release of prolactin, thyroid stimulating hormone (TSH), growth hormone (GH), luteinizing hormone (LH), and cortisol. Fifteen schizophrenic patients with positive and negative symptomatology, respectively, were treated with roxindole for 28 days. Both basal and thyrotropin releasing hormone (TRH) -induced prolactin secretion diminished significantly to 26.4…

AdultMaleendocrine systemmedicine.medical_specialtyIndolesHydrocortisoneendocrine system diseasesPyridinesThyrotropinThyrotropin-releasing hormonePharmacologyDopamine agonistchemistry.chemical_compoundThyroid-stimulating hormoneAnterior pituitaryRoxindoleInternal medicinemedicineHumansPharmacologybusiness.industryLuteinizing HormoneMiddle AgedProlactinGrowth hormone secretionOxindolesProlactinEndocrinologymedicine.anatomical_structurechemistryGrowth HormoneDopamine AgonistsSchizophreniaFemaleSchizophrenic PsychologyLuteinizing hormonebusinesshormones hormone substitutes and hormone antagonistsmedicine.drugPsychopharmacology
researchProduct

Apomorphine-Induced Growth Hormone Response Is Attenuated by Ethanol but Not Dextromethorphan

2007

Background: Misuse of alcohol drinking is a major health problem. Alcohol decreases spontaneous growth hormone (GH) secretion, but the mechanism is unclear. The aim of this study was to test whether administration of alcohol (study 1) or a N-methyl d-aspartate (NMDA) receptor antagonist (study 2) attenuates the GH response to pharmacological dopaminergic stimulation. Methods: The 2-session repeated measures design was conducted at the endocrine laboratory at the Department of Psychiatry at the Free University Berlin. Twenty healthy Caucasian males aged 35±10 years without a history of alcohol use disorders were tested using the Apomorphine (APO) challenge test. In study 1, we injected APO (…

AdultMalemedicine.medical_specialtyApomorphineMedicine (miscellaneous)PharmacologyToxicologyPlaceboDextromethorphanReceptors N-Methyl-D-Aspartatechemistry.chemical_compoundOral administrationInternal medicinemedicineHumansEthanolEthanolHuman Growth Hormonebusiness.industryDopaminergicCentral Nervous System DepressantsDextromethorphanGrowth hormone secretionApomorphinePsychiatry and Mental healthEndocrinologychemistryArea Under CurveDopamine AgonistsNMDA receptorbusinessmedicine.drugAlcoholism: Clinical and Experimental Research
researchProduct

LONG-ACTING AND SELECTIVE SUPPRESSION OF GROWTH HORMONE SECRETION BY SOMATOSTATIN ANALOGUE SMS 201-995 IN ACROMEGALY

1984

In 6 of 7 acromegalic patients a single subcutaneous injection of 50 micrograms of a new octapeptide somatostatin analogue (SMS 201-995) reduced serum growth hormone (GH) from 30 +/- 12 ng/ml to 1.4 +/- 0.4 (mean +/- SEM). Serum GH remained below basal concentration for 9 h. In the remaining patient who had very high basal preprandial serum GH, SMS 201-995 produced a reduction in serum GH of only 20%. Plasma glucose concentrations were increased to the upper limits of the normal range when a high-carbohydrate meal was consumed 2 h after injection. In non-diabetic patients plasma glucose did not exceed 129 mg/dl. The 40% decrease in plasma glucagon, which lasted for 7 h after SMS 201-995 inj…

Adultmedicine.medical_specialtyTime Factorsmedicine.medical_treatmentPeptide hormoneOctreotideEatingSubcutaneous injectionInternal medicineAcromegalymedicineHumansInsulinAgedChemotherapyMealChemistryGeneral MedicineGlucose Tolerance TestMiddle AgedGlucagonmedicine.diseaseGrowth hormone secretionEndocrinologySomatostatinBasal (medicine)Growth HormoneAcromegalySomatostatinThe Lancet
researchProduct

Impaired GH secretion in patients with SHOX deficiency and efficacy of recombinant human GH therapy.

2012

<b><i>Background/Aims:</i></b> Mutations of the short stature homeobox-containing <i>(SHOX)</i> gene on the pseudoautosomal region of the sex chromosomes cause short stature. GH treatment has been recently proposed to improve height in short patients with SHOX deficiency. The aim of this study was to evaluate GH secretion and analyze growth and safety of recombinant human GH (rhGH) therapy in short children and adolescents with SHOX deficiency. <b><i>Patients and Design:</i></b> We studied 16 patients (10 females; 9.7 ± 2.9 years old; height –2.46 ± 0.82 standard deviation score, SDS) with SHOX deficiency. All subjects underwent au…

MaleLanger-Giedion SyndromeEndocrinology Diabetes and MetabolismSHOX deficiencyPseudoautosomal regionMadelung deformityLer Weill syndromelaw.inventionEndocrinologySettore MED/38 - Pediatria Generale E SpecialisticaShort Stature Homeobox ProteinGH treatmentShort Stature Homeobox ProteinlawSHOX DeficiencyChildGrowth DisordersHuman Growth HormoneGrowth hormone secretionRecombinant ProteinsGHRecombinant Human GHChild PreschoolRecombinant DNAFemalemedicine.symptomSHOX Deficiencymedicine.medical_specialtyAdolescentNoseOsteochondrodysplasiasShort statureFingersInternal medicinemedicineHumansLéri–Weill dyschondrosteosisGeneLeri-Weill dyschondrosteosiHomeodomain Proteinsbusiness.industrymedicine.diseaseBody HeightSHOX Deficiency; Ler Weill syndrome; Recombinant Human GHShort statureEndocrinologyGrowth HormonePediatrics Perinatology and Child HealthbusinessHair DiseasesSHOX
researchProduct

Correlation between adrenal function, growth hormone secretion, and insulin sensitivity in children with idiopathic growth hormone deficiency

2017

Purpose Patients with growth hormone deficiency (GHD) demonstrate an increased cortisol/cortisone ratio which could potentially explain the metabolic features of GHD, while GH treatment (GHT) could increase the cortisol metabolism. Methods In 35 children (27 M, mean age 10.1 years) with idiopathic GHD at baseline and after 12 months of GHT and in 25 controls, in addition to metabolic parameters, we assessed adrenal function by morning serum cortisol, its peak, and its area under the curve (AUCCOR) during insulin tolerance test (ITT). Results A cortisol peak <18 µg/dl was shown in 22 and 31% of GHD children at baseline and after GHT, respectively. At baseline, GHD children had lower fasting …

Malemedicine.medical_specialtyGHD adrenal insufficiencyCortisol awakening responseHydrocortisoneEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismSettore MED/13 - EndocrinologiaGrowth hormone deficiency03 medical and health sciences0302 clinical medicineEndocrinologyInsulin resistanceInternal medicineAdrenal GlandsmedicineHumansProspective Studies030212 general & internal medicineChildDwarfism PituitaryMorningHydrocortisoneHuman Growth Hormonebusiness.industryInsulin tolerance testPrognosismedicine.diseaseGrowth hormone secretionEndocrinologyCase-Control StudiesChild PreschoolFemaleAdrenal Cortex Function TestsInsulin ResistanceCortisonebusinessBiomarkershormones hormone substitutes and hormone antagonistsFollow-Up Studiesmedicine.drugJournal of Endocrinological Investigation
researchProduct

Differential effect of hypophysectomy and growth hormone treatment on hepatic glucuronosyltransferases in male rats: Evidence for an action at a pret…

1997

International audience; The influence of growth hormone (GH) on 4-nitrophenol, bilirubin, testosterone, androsterone and estrone glucuronidation activities was studied in fully activated male rat hepatic microsomes. Sham-operated and hypophysectomized animals were injected with two different dosages of GH, mimicking either the male or female GH secretion pattern. Half the animals received thyroxine and cortisol in concentrations chosen to compensate for the lack of thyroid hormones and glucocorticoids in hypophysectomized rats. GH induced a decrease in several glucuronidation activities: bilirubin glucuronidation in both sham-operated and cortisol/ thyroxine-treated hypophysectomized rats i…

Malemedicine.medical_specialtyHypophysectomyGlucuronosyltransferaseHydrocortisoneBilirubin[SDV]Life Sciences [q-bio]medicine.medical_treatmentImmunoblottingGlucuronidationEstronePolymerase Chain ReactionBiochemistryRats Sprague-DawleyRat Biochimie03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicinemedicineAnimalsRNA MessengerGlucuronosyltransferaseObjet d'étude : rattus rattus ; foie Composé chimique Facteur du milieu : transférase ; hormone de croissance Dispositif technique et méthode d'étude : médicament ; hypophysectomie Phénomène processus et fonction : pulsatilitéTestosteroneHypophysectomy030304 developmental biologyPharmacology0303 health sciencesAndrosteronebiologyDiscriminant AnalysisBilirubinGrowth hormone secretionRats[SDV] Life Sciences [q-bio]IsoenzymesThyroxineEndocrinologychemistryGrowth HormoneProtein Biosynthesis030220 oncology & carcinogenesisMicrosomes Liverbiology.proteinBiochemical Pharmacology
researchProduct

Relapse prevention in alcoholics by cigarette smoking? Involvement of nicotinic-dopaminergic mechanisms.

2001

Because of a controversial view on the role of smoking in the recovery process of alcoholism, outcome data obtained for alcoholics who had been included in a long-term clinical trial with a putative anticraving drug were analyzed. To avoid unknown interactions between the drug under study and smoking behavior, only placebo-treated patients were evaluated in this investigation. After 12 months of rehabilitation, there was no significant difference regarding abstinence rate between 48 smoking alcoholics (who reported that they smoked 32 cigarettes on average per day) and 15 nonsmoking alcoholics (33% vs. 20%). However, smokers tended to be abstinent longer than nonsmokers (173 vs. 114 days; P…

Malemedicine.medical_specialtyNicotineHealth (social science)Apomorphinemedia_common.quotation_subjectDopaminePhysiologyToxicologyRelapse preventionBiochemistryNicotineBehavioral NeuroscienceInternal medicinemedicineSecondary PreventionHumansmedia_commonAgedRandomized Controlled Trials as TopicEthanolHuman Growth HormoneAlcohol dependenceSmokingArea under the curveGeneral MedicineTobacco Use DisorderAbstinenceMiddle AgedGrowth hormone secretionClinical trialAlcoholismEndocrinologyNeurologyToxicityDopamine AgonistsFemalePsychologymedicine.drugAlcohol (Fayetteville, N.Y.)
researchProduct

Sequential contrast-enhanced magnetic resonance imaging in the diagnosis of growth hormone deficiencies

1999

The purpose of the present study was to assess the presence and the time-course of contrast-enhancement in the pituitary gland and pituitary stalk of 24 patients with isolated growth hormone (GH) deficiency and multiple pituitary hormone deficiency. The patients were evaluated clinically (auxological measurements), endocrinologically (spontaneous GH secretion and GH stimulation tests) and with conventional MRI scans. In addition, fast-framing dynamic magnetic resonance imaging (MRI) with Gd-DTPA enhancement was used to quantitate the time course of contrast enhancement within the neurohypophysis, pituitary stalk, postero-superior adenohypophysis and antero-inferior adenohypophysis. In 3 pat…

Malemedicine.medical_specialtyPathologyPituitary glandSomatotropic cellGH deficienciesEndocrinology Diabetes and MetabolismPortal venous systemPathogenesisEndocrinologyInternal medicinemedicineHumansChildGrowth hormoneGrowth DisordersPituitary stalkmedicine.diagnostic_testHuman Growth Hormonebusiness.industryMagnetic resonance imagingMagnetic Resonance ImagingGrowth hormone secretionEndocrinologymedicine.anatomical_structureContrast-enhancementPituitary GlandSequential MRIFemalebusinessMRIHormoneJournal of Endocrinological Investigation
researchProduct

Basal growth hormone concentrations in blood and the risk for prostate cancer: A case-control study

2005

OBJECTIVE To assess the relationship between basal serum growth hormone (GH) levels and prostate cancer risk. METHODS We conducted a population-based case-control study; cases included 68 men, aged 45–85 years, diagnosed with incident, primary, histologically confirmed, and clinically apparent (stage B and higher) prostate cancer. Controls included 240 men, frequency matched on age and residential area. Age, race, BMI, waist circumference, history of enlarged prostate, education, and current smoking status, were all considered as possible confounders. RESULTS We found a statistically significant trend of decreasing prostate cancer risk across increasing GH quintiles, in both crude (OR: 0.31…

Malemedicine.medical_specialtyWaistUrologyPopulationGastroenterologyProstate cancerBasal (phylogenetics)Risk FactorsInternal medicineBiomarkers TumormedicineHumansInsulin-Like Growth Factor IRisk factoreducationAgedAged 80 and overeducation.field_of_studybusiness.industryConfoundingCase-control studyProstatic NeoplasmsMiddle Agedmedicine.diseaseGrowth hormone secretionEndocrinologyOncologyCase-Control StudiesGrowth HormonebusinessThe Prostate
researchProduct